Scheduled Inside Plastic Stent Exchange Prevents Cholangitis and Reduces Unplanned Hospitalization in Patients With Unresectable Malignant Hilar Biliary Obstruction
DEN Open · 2026-04 · 6 (1)
DOI: 10.1002/deo2.70242 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 10.11.2025. Verfasst von Joji Muramatsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Internal Medicine Sapporo Medical University School of Medicine Hokkaido Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To prevent cholangitis in patients with unresectable malignant hilar biliary obstruction (MHBO), we recently implemented scheduled inside plastic stent (IS) exchange every 2–4 months. This study aimed to evaluate whether this strategy prevents cholangitis onset and reduces unplanned hospitalizations without increasing adverse events.
Methods
This retrospective single‐center study included patients with unresectable MHBO who underwent IS placement between 2011 and 2023. Patients were divided into two groups: those who underwent scheduled IS exchange (scheduled group, n = 12) and those who received on‐demand IS exchange (on‐demand group, n = 29). We compared unplanned hospitalization duration and number, time from initial IS placement to cholangitis onset, 1‐year cholangitis‐free rate from initial IS placement, cholangitis severity, adverse events, medical costs, duration of antitumor therapy, and prognosis.
Results
Median duration of unplanned hospitalizations was significantly shorter in the scheduled group compared to the on‐demand group (0 days [range: 0–83] vs. 38.5 days [0–140], p = 0.03). The time from initial IS placement to the onset of cholangitis was also significantly longer in the scheduled group (median 203 days [range: 54–463] vs. 89 days [4–1081], p = 0.02). The 1‐year cholangitis‐free rate was significantly higher in the scheduled group (50% vs. 10%, p = 0.01). No significant differences were found in the number of unplanned hospitalizations, cholangitis severity, adverse events, medical costs, duration of antitumor therapy, or prognosis.
Conclusions
Scheduled IS exchange delays the onset of cholangitis and reduces the duration of unplanned hospitalizations without increasing adverse events.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Internal Medicine Sapporo Medical University School of Medicine Hokkaido Japan.
- Department of Gastroenterology Oji General Hospital Hokkaido Japan.
- Department of Gastroenterology Otaru Ekisaikai Hospital Hokkaido Japan.
- Department of Gastroenterology Rumoi City Hospital Hokkaido Japan.
ORCID-Profile: Joji Muramatsu, Kazuma Ishikawa, Tomohiro Kubo, Makoto Yoshida, Kohichi Takada
Zitieren
APA
Muramatsu, J., Ishikawa, K., Suzuki, N., Kubo, T., Yoshida, M., Omori, G., Ito, R., Miura, S., & Takada, K. (2026). Scheduled Inside Plastic Stent Exchange Prevents Cholangitis and Reduces Unplanned Hospitalization in Patients With Unresectable Malignant Hilar Biliary Obstruction. DEN Open, 6(1). https://doi.org/10.1002/deo2.70242
Vancouver
Muramatsu J, Ishikawa K, Suzuki N, Kubo T, Yoshida M, Omori G, et al. Scheduled Inside Plastic Stent Exchange Prevents Cholangitis and Reduces Unplanned Hospitalization in Patients With Unresectable Malignant Hilar Biliary Obstruction. DEN Open. 2026;6(1). doi:10.1002/deo2.70242
BibTeX
@article{Muramatsu2026,
author = {Muramatsu, Joji and Ishikawa, Kazuma and Suzuki, Norito and Kubo, Tomohiro and Yoshida, Makoto and Omori, Ginji and Ito, Ryo and Miura, Shogo and Takada, Kohichi},
title = {Scheduled Inside Plastic Stent Exchange Prevents Cholangitis and Reduces Unplanned Hospitalization in Patients With Unresectable Malignant Hilar Biliary Obstruction},
journal = {DEN Open},
year = {2026},
volume = {6},
number = {1},
doi = {10.1002/deo2.70242}
}
EUVIMED